Article
Oncology
Yunlang She, Shenghui Li, Jiajun Deng, Yijiu Ren, Mengmeng Zhao, Yifan Zhong, Yiming He, Qiankun Chen, Deping Zhao, Yuming Zhu, Likun Hou, Chunyan Wu, Dong Xie, Chang Chen
Summary: This study evaluated the clinicopathologic characteristics and prognostic impact of atypical EGFR mutations in patients with completely resected LUAD. The results showed that the L861Q mutation was an independent prognostic factor for DFS in patients with atypical EGFRm LUAD. Additionally, adjuvant chemotherapy did not improve survival outcomes for these patients.
EUROPEAN JOURNAL OF CANCER
(2022)
Article
Oncology
Yoshiya Matsumoto, Tomoya Kawaguchi, Masaru Watanabe, Shun-ichi Isa, Masahiko Ando, Akihiro Tamiya, Akihito Kubo, Chiyoe Kitagawa, Naoki Yoshimoto, Yasuhiro Koh
Summary: This study found that minor-frequency pretreatment T790M mutation, especially high-abundance one, is associated with a poor prognosis in patients with surgically resected, EGFR-mutated non-small cell lung cancer.
Article
Oncology
Shinkichi Takamori, Mototsugu Shimokawa, Taichi Matsubara, Naoki Haratake, Ryo Toyozawa, Naoko Miura, Masafumi Yamaguchi, Takashi Seto, Tetsuzo Tagawa, Tatsuro Okamoto, Mitsuhiro Takenoyama, Yoshihiko Maehara, Masaki Mori
Summary: The study analyzed 1134 NSCLC patients with smoking history who underwent curative lung resection at a single center in Japan between 2000 and 2016, finding that smoking period was an independent predictor of DFS and OS, with superior AUC values compared to number of packs smoked per day. Patients with a smoking period >= 40 years had significantly shorter DFS and OS than those with a smoking period of < 40 years.
ANNALS OF SURGICAL ONCOLOGY
(2021)
Article
Oncology
Wei Guo, Tao Zhang, Runze Li, Xiaoxi Chen, Jiaohui Pang, Hua Bao, Xue Wu, Yang Shao, Bin Qiu, Shugeng Gao, Jie He
Summary: Locoregional recurrence is a high-risk factor for poor prognosis in NSCLC, and its associated genomic biomarkers have been inadequately studied. This study identified genomic biomarkers from tumor and ctDNA samples that showed promising prognostic value for patients with locoregional recurrence only.
Article
Oncology
Nussara Pakvisal, Poonchavist Chantranuwat, Chanida Vinayanuwattikun, Piyada Sitthideatphaiboon, Chinachote Teerapakpinyo, Shanop Shuangshoti, Vichai Benjacholamas, Nopporn Pornpattanarak, Virote Sriuranpong
Summary: This study retrospectively reviewed completely resected N0 pulmonary adenocarcinoma patients treated in the hospital between 2009 and 2016. The findings highlighted tumor size, visceral pleural invasion, tumor necrosis, and resection margin distance as significant pathological prognostic factors for recurrence risk in this patient population.
TRANSLATIONAL CANCER RESEARCH
(2022)
Article
Cardiac & Cardiovascular Systems
Chaoqiang Deng, Yang Zhang, Zelin Ma, Fangqiu Fu, Lin Deng, Yuan Li, Haiquan Chen
Summary: Mutation of the EGFR gene is a significant poor prognostic factor in lung adenocarcinoma patients, especially in those with solid tumors and specific histologic types, as well as in patients with pathologic stage II and III. Following surgery, patients with EGFR mutations are more prone to brain and bone metastases.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
(2021)
Editorial Material
Oncology
Yu Chen, Jinming Yu, Xiangjiao Meng
Summary: This commentary emphasizes the potential of postoperative radiotherapy in patients with completely resected IIIA-N2 non-small cell lung cancer.
Article
Oncology
Virginie Westeel, Pascal Foucher, Arnaud Scherpereel, Jean Domas, Philippe Girard, Jean Tredaniel, Marie Wislez, Patrick Dumont, Elisabeth Quoix, Olivier Raffy, Denis Braun, Marc Derollez, Francois Goupil, Jacques Hermann, Etienne Devin, Hubert Barbieux, Eric Pichon, Didier Debieuvre, Gervais Ozenne, Jean-Francois Muir, Stephanie Dehette, Jerome Virally, Michel Grivaux, Francois Lebargy, Pierre-Jean Souquet, Faraj Al Freijat, Nicolas Girard, Emmanuel Courau, Reza Azarian, Michel Farny, Jean-Paul Duhamel, Alexandra Langlais, Franck Morin, Bernard Milleron, Gerard Zalcman, Fabrice Barlesi
Summary: This study evaluates the efficacy of postoperative follow-up methods for patients with resectable NSCLC. The results show that there is no significant difference in survival and disease-free survival between the follow-up group and the minimal follow-up group in the intention-to-treat population. However, CT-based follow-up enables earlier detection of recurrence and second primary lung cancer, which can be treated with curative intent.
Article
Oncology
Reza Zarinshenas, Colton Ladbury, Heather McGee, Dan Raz, Loretta Erhunmwunsee, Ranjan Pathak, Scott Glaser, Ravi Salgia, Terence Williams, Arya Amini
Summary: This study used machine learning algorithms to analyze the feasibility of post-operative radiotherapy in patients with completely resected N2 non-small-cell lung cancer. The results showed that post-operative radiotherapy significantly improved overall survival in patients with a lymph node burden of 3+ positive lymph nodes or a lymph node ratio of 0.34+.
RADIOTHERAPY AND ONCOLOGY
(2022)
Article
Surgery
Maximilian Evers, Anja Rinke, Johannes Ruetz, Annette Ramaswamy, Elisabeth Maurer, Detlef K. Bartsch
Summary: In this study, age >= 60 years, tumor size >= 2 cm, lymph node ratio > 0.5, and multifocal tumor growth were identified as independent negative prognostic factors for patients with locoregional SI-NEN. In contrast, right hemicolectomy was found to be an independent factor protecting against disease recurrence.
WORLD JOURNAL OF SURGERY
(2021)
Article
Multidisciplinary Sciences
Fumihiko Kinoshita, Tomoyoshi Takenaka, Takanori Yamashita, Koutarou Matsumoto, Yuka Oku, Yuki Ono, Sho Wakasu, Naoki Haratake, Tetsuzo Tagawa, Naoki Nakashima, Masaki Mori
Summary: This study aimed to develop an AI prognostic model for surgically resected non-small cell lung cancer (NSCLC) using the eXtreme Gradient Boosting (XGBoost) machine learning algorithm. The AI model showed good prediction accuracy and provided accurate predictive probability of postoperative prognosis of NSCLC.
SCIENTIFIC REPORTS
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Hsiu-Ping Chou, Kuan-Hsun Lin, Hsu-Kai Huang, Li-Fan Lin, Ying-Yi Chen, Ti-Hui Wu, Shih-Chun Lee, Hung Chang, Tsai-Wang Huang
Summary: SUVmax was identified as a prognostic factor for resected stage IA NSCLC, providing potential clinical significance. Postoperative treatment may be considered for stage IA3 NSCLC with SUVmax > 4.
EUROPEAN RADIOLOGY
(2021)
Article
Medicine, Research & Experimental
Chihiro Yoshida, Kyuichi Kadota, Kaede Yamada, Syusuke Fujimoto, Emi Ibuki, Ryou Ishikawa, Reiji Haba, Toshiki Yajima
Summary: This study investigated the correlation between CD44 and its variant isoforms with prognostic factors for distant metastasis in stage I lung adenocarcinomas. The expression of CD44v6 was significantly associated with the risk of recurrence and poor prognosis. CD44v6-negative tumors had a higher risk of distant recurrence and were related to invasive tumor size and lymphovascular invasion.
CLINICAL AND EXPERIMENTAL MEDICINE
(2023)
Article
Biochemistry & Molecular Biology
Wei Guo, Qilin Huai, Huan Wan, Lei Guo, Peng Song, Shugeng Gao, Jie He
Summary: Through analysis of multiple datasets, it is found that IGF2BP3 is abnormally highly expressed in LUAD, leading to worse prognosis. This suggests that IGF2BP3 may be an oncogene and potential prognostic biomarker for LUAD.
DNA AND CELL BIOLOGY
(2021)
Article
Oncology
Huan Zhang, Guangyao Shan, Benjie Cai, Guoshu Bi, Zhencong Chen, Jiaqi Liang, Valeria Besskaya, Yuansheng Zheng, Weigang Guo, Lin Wang, Songtao Xu, Cheng Zhan
Summary: Patients with ALK rearranged lung adenocarcinoma who have undergone radical surgery have distinct clinical features, with better prognosis and a higher likelihood of benefiting from targeted therapy, especially for stage II-III patients.
Article
Oncology
Bo Hwa Sohn, Jae-Jun Shim, Sang-Bae Kim, Kyu Yun Jang, Soo Mi Kim, Ji Hoon Kim, Jun Eul Hwang, Hee-Jin Jang, Hyun-Sung Lee, Sang-Cheol Kim, Woojin Jeong, Sung Soo Kim, Eun Sung Park, Jeonghoon Heo, Yoon Jun Kim, Dae-Ghon Kim, Sun-Hee Leem, Ahmed Kaseb, Manal M. Hassan, Minse Cha, In-Sun Chu, Randy L. Johnson, Yun-Yong Park, Ju-Seog Lee
CLINICAL CANCER RESEARCH
(2016)
Article
Gastroenterology & Hepatology
Yun-Yong Park, Bo Hwa Sohn, Randy L. Johnson, Myoung-Hee Kang, Sang Bae Kim, Jae-Jun Shim, Lingegowda S. Mangala, Ji Hoon Kim, Jeong Eun Yoo, Cristian Rodriguez-Aguayo, Sunila Pradeep, Jun Eul Hwang, Hee-Jin Jang, Hyun-Sung Lee, Rajesha Rupaimoole, Gabriel Lopez-Berestein, Woojin Jeong, Inn Sun Park, Young Nyun Park, Anil K. Sood, Gordon B. Mills, Ju-Seog Lee
Article
Gastroenterology & Hepatology
Hee-Jin Jang, Hyun-Sung Lee, Bryan M. Burt, Geon Kook Lee, Kyong-Ah Yoon, Yun-Yong Park, Bo Hwa Sohn, Sang Bae Kim, Moon Soo Kim, Jong Mog Lee, Jungnam Joo, Sang Cheol Kim, Ju Sik Yun, Kook Joo Na, Yoon-La Choi, Jong-Lyul Park, Seon-Young Kim, Yong Sun Lee, Leng Han, Han Liang, Duncan Mak, Jared K. Burks, Jae Ill Zo, David J. Sugarbaker, Young Mog Shim, Ju-Seog Lee
Article
Multidisciplinary Sciences
Sang Cheul Oh, Bo Hwa Sohn, Jae-Ho Cheong, Sang-Bae Kim, Jae Eun Lee, Ki Cheong Park, Sang Ho Lee, Jong-Lyul Park, Yun-Yong Park, Hyun-Sung Lee, Hee-Jin Jang, Eun Sung Park, Sang-Cheol Kim, Jeonghoon Heo, In-Sun Chu, You-Jin Jang, Young-Jae Mok, WonKyung Jung, Baek-Hui Kim, Aeree Kim, Jae Yong Cho, Jae Yun Lim, Yuki Hayashi, Shumei Song, Elena Elimova, Jeannelyn S. Estralla, Jeffrey H. Lee, Manoop S. Bhutani, Yiling Lu, Wenbin Liu, Jeeyun Lee, Won Ki Kang, Sung Kim, Sung Hoon Noh, Gordon B. Mills, Seon-Young Kim, Jaffer A. Ajani, Ju-Seog Lee
NATURE COMMUNICATIONS
(2018)
Article
Multidisciplinary Sciences
Ji-Hye Ahn, Hyun-Sung Lee, Ju-Seog Lee, Yeon-Su Lee, Jong-Lyul Park, Seon-Young Kim, Jung-Ah Hwang, Nawapol Kunkeaw, Sung Yun Jung, Tae Jin Kim, Kwang-Soo Lee, Sung Ho Jeon, Inhan Lee, Betty H. Johnson, Jung-Hye Choi, Yong Sun Lee
NATURE COMMUNICATIONS
(2018)
Letter
Oncology
Hyun-Sung Lee, Cynthia Y. Truong, Bryan M. Burt
JOURNAL OF THORACIC ONCOLOGY
(2018)
Article
Multidisciplinary Sciences
Nawapol Kunkeaw, Yeon-Su Lee, Wonkyun Ronny Im, Jiyoung Joan Jang, Min-Ji Song, Bobae Yang, Jong-Lyul Park, Seon-Young Kim, Yongsuk Ku, Yoosik Kim, Sangmin Kang, Hye-ram Jo, Jae-Hoon Jeong, Hyun-Sung Lee, Ju-Seog Lee, Hyoung-Pyo Kim, Betty H. Johnson, In-Hoo Kim, Yong Sun Lee
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2019)
Article
Cell Biology
Wonkyun Ronny Im, Hyun-Sung Lee, Yeon-Su Lee, Ju-Seog Lee, Hee-Jin Jang, Seon-Young Kim, Jong-Lyul Park, Yeontaek Lee, Moon Soo Kim, Jong Mog Lee, In-Hoo Kim, Sung Ho Jeon, Yong Sun Lee
Article
Biochemistry & Molecular Biology
Yeon-Su Lee, Xiaoyong Bao, Hwi-Ho Lee, Jiyoung Joan Jang, Enkhjin Saruuldalai, Gaeul Park, Wonkyun Ronny Im, Jong-Lyul Park, Seon-Young Kim, Sooyong Shin, Sung Ho Jeon, Sangmin Kang, Hyun-Sung Lee, Ju-Seog Lee, Ke Zhang, Eun Jung Park, In-Hoo Kim, Yong Sun Lee
Summary: The noncoding RNA nc886 acts as a novel suppressor for the IFN-beta signaling and inflammation by inhibiting the activation of IRF3, NF-kappa B, and AP-1 through inhibiting PKR. This leads to decreased expression of IFN-beta and IFN-stimulated genes. Its role is to restrict the IFN-beta signaling from hyperactivation, which may explain the variability of innate immune responses to pathogens based on biological settings.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Oncology
Hee-Jin Jang, Hyun-Sung Lee, Wendong Yu, Maheshwari Ramineni, Cynthia Y. Truong, Daniela Ramos, Taylor Splawn, Jong Min Choi, Sung Yun Jung, Ju-Seog Lee, Daniel Y. Wang, Joel M. Sederstrom, Massimo Pietropaolo, Farrah Kheradmand, Christopher Amos, Thomas M. Wheeler, R. Taylor Ripley, Bryan M. Burt
Summary: Comprehensive single-cell proteomics analyses reveal the role of tumor-associated macrophages in resistance to PD-1 blockade therapy in lung adenocarcinoma progression. The spatiotemporal evolution of tumor-associated macrophages in the tumor-immune micro-environment governs tumor response to immunotherapy. PD-1 expression in a tumor-promoting subtype of tumor-associated macrophages controls tumor progression and protects tumor cells.
Article
Oncology
Thinh T. Nguyen, Hyun-Sung Lee, Bryan M. Burt, Christopher Amos, Chao Cheng
Summary: This study found that gene signature scores were more prognostic than genomic mutations, mRNA, and protein expression in malignant pleural mesothelioma (MPM). High immune infiltration levels were associated with prolonged survival. The integrated model combining intrinsic and extrinsic features provided independent prognostic values in MPM.
BRITISH JOURNAL OF CANCER
(2022)
Article
Oncology
Amanda M. Nash, Samira Aghlara-Fotovat, Bertha Castillio, Andrea Hernandez, Aarthi Pugazenthi, Hyun-Sung Lee, Hee-Jin Jang, Annie Nguyen, Alexander Lu, Bryan M. Burt, Ravi K. Ghanta, Omid Veiseh
Summary: The IL2 cytokine factories showed significant therapeutic efficacy in treating malignant mesothelioma in a mouse model, enhancing the effectiveness of therapy through activation of immune cells, and the safety and translatability of the treatment system were also validated.
CLINICAL CANCER RESEARCH
(2022)
Article
Oncology
Hyun-Sung Lee, Hee-Jin Jang, Maheshwari Ramineni, Daniel Y. Wang, Daniela Ramos, Jong Min Choi, Taylor Splawn, Monica Espinoza, Michelle Almarez, Leandria Hosey, Eunji Jo, Susan Hilsenbeck, Christopher I. Amos, R. Taylor Ripley, Bryan M. Burt
Summary: This study compared the effects of monotherapy and combination therapy on pathological response and survival in resectable patients. The results showed that combination therapy can alter the immune microenvironment of malignant pleural mesothelioma tumors and improve overall survival.
CLINICAL CANCER RESEARCH
(2023)
Article
Multidisciplinary Sciences
Younghun Y. Han, Jinyoung J. Byun, Catherine Zhu, Ryan R. Sun, Julia Y. Roh, Heather Cordell, Hyun-Sung A. Lee, Vikram R. Shaw, Sung Wook Kang, Javad Razjouyan, Matthew A. Cooley, Manal M. Hassan, Katherine A. Siminovitch, Trine Folseraas, David Ellinghaus, Annika Bergquist, Simon M. Rushbrook, Andre Franke, Tom H. Karlsen, Konstantinos N. Lazaridis, Katherine A. McGlynn, Lewis R. Roberts, Christopher Amos, Christoph Schramm, David Shapiro, Elizabeth Goode
Summary: This study used multitrait joint analyses to explore the genetic contribution and correlations between various clinical and epidemiological traits associated with PSC. Several new risk loci and potential susceptibility genes such as MANBA and IRF5 were identified, and in silico drug screening provided candidate agents for further investigation of pharmacological effects in PSC.
NATURE COMMUNICATIONS
(2023)
Article
Medicine, Research & Experimental
Hyun-Sung Lee, Hee-Jin Jang, Jong Min Choi, Jun Zhang, Veronica Lenge de Rosen, Thomas M. Wheeler, Ju-Seog Lee, Thuydung Tu, Peter T. Jindra, Ronald H. Kerman, Sung Yun Jung, Farrah Kheradmand, David J. Sugarbaker, Bryan M. Burt